Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | 0 | uM | 9 | 1250.00 | 684.27 | 1697.00 | 1780.00 | 0.9534 | 0.9319 | |
| BT-20 | Erlotinib | 0.01 | uM | 9 | 1250.00 | 684.27 | 1643.00 | 1780.00 | 0.9230 | 0.8872 |
| BT-20 | Erlotinib | 3.1623 | uM | 9 | 1250.00 | 684.27 | 1409.00 | 1780.00 | 0.7916 | 0.6882 |
| BT-20 | 17-AAG | 0.31623 | uM | 9 | 1250.00 | 684.27 | 636.00 | 1780.00 | 0.3573 | -0.0517 |
| BT-20 | Linsitinib | 19.9526 | uM | 9 | 1250.00 | 684.27 | 968.00 | 1780.00 | 0.5438 | 0.2860 |
| BT-20 | Linsitinib | 0.01 | uM | 9 | 1250.00 | 684.27 | 2015.00 | 1780.00 | 1.1320 | 1.1881 |
| BT-20 | Linsitinib | 0.031623 | uM | 9 | 1250.00 | 684.27 | 1943.00 | 1780.00 | 1.0916 | 1.1312 |
| BT-20 | Lapatinib | 0.01 | uM | 9 | 1250.00 | 684.27 | 1883.00 | 1780.00 | 1.0579 | 1.0833 |
| BT-20 | 17-AAG | 0.031623 | uM | 9 | 1250.00 | 684.27 | 586.00 | 1780.00 | 0.3292 | -0.1063 |
| BT-20 | Lapatinib | 0.1 | uM | 9 | 1250.00 | 684.27 | 1929.00 | 1780.00 | 1.0837 | 1.1200 |
| BT-20 | Erlotinib | 0.31623 | uM | 9 | 1250.00 | 684.27 | 1789.00 | 1780.00 | 1.0051 | 1.0073 |
| BT-20 | Linsitinib | 0.31623 | uM | 9 | 1250.00 | 684.27 | 2049.00 | 1780.00 | 1.1511 | 1.2149 |
| BT-20 | Lapatinib | 0.0016596 | uM | 9 | 1250.00 | 684.27 | 2028.00 | 1780.00 | 1.1393 | 1.1984 |
| BT-20 | 17-AAG | 0.01 | uM | 9 | 1250.00 | 684.27 | 1011.00 | 1780.00 | 0.5680 | 0.3271 |
| BT-20 | Lapatinib | 0.031623 | uM | 9 | 1250.00 | 684.27 | 1955.00 | 1780.00 | 1.0983 | 1.1407 |
| BT-20 | Lapatinib | 0.0033113 | uM | 9 | 1250.00 | 684.27 | 1851.00 | 1780.00 | 1.0399 | 1.0575 |
| BT-20 | 17-AAG | 0.1 | uM | 9 | 1250.00 | 684.27 | 636.00 | 1780.00 | 0.3573 | -0.0517 |
| BT-20 | Linsitinib | 0.0033113 | uM | 9 | 1250.00 | 684.27 | 1887.00 | 1780.00 | 1.0601 | 1.0865 |
| BT-20 | Linsitinib | 3.1623 | uM | 9 | 1250.00 | 684.27 | 1726.00 | 1780.00 | 0.9697 | 0.9558 |
| BT-20 | Erlotinib | 0.0033113 | uM | 9 | 1250.00 | 684.27 | 1803.00 | 1780.00 | 1.0129 | 1.0187 |
| BT-20 | Lapatinib | 1 | uM | 9 | 1250.00 | 684.27 | 1471.00 | 1780.00 | 0.8264 | 0.7418 |
| BT-20 | 0 | uM | 9 | 1250.00 | 684.27 | 1704.00 | 1780.00 | 0.9573 | 0.9377 | |
| BT-20 | 0 | uM | 9 | 2500.00 | 1434.95 | 3266.00 | 3812.75 | 0.8566 | 0.7920 | |
| BT-20 | Linsitinib | 0.1 | uM | 9 | 2500.00 | 1434.95 | 3761.00 | 3812.75 | 0.9864 | 0.9807 |
| BT-20 | Lapatinib | 3.1623 | uM | 9 | 2500.00 | 1434.95 | 2973.00 | 3812.75 | 0.7798 | 0.6765 |